Chorionic villus sampling and the risk of adverse outcome in patients undergoing multifetal pregnancy reduction

CVS prior to MPR does not increase the risk of pregnancy loss. Our data suggest that CVS prior to singleton reduction may decrease the risk of adverse outcome.